PETCT in the contemporary management of breast cancer

PETCT has been relatively underused in breast cancer in comparison to some other tumour types, partly due to a lack of access to scanners, but also due to a lack of clear evidence for a defined role. As access and funding improves, it is important for the breast oncology and radiology communities to agree on guidelines for referral for PETCT to help multi-disciplinary teams identify appropriate patients. This review examines the evidence for PETCT throughout the stages and settings of breast cancer, including diagnosis, staging of local and distant disease, molecular imaging and assessment of response to treatment.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.